Search Login Register

Dipyridamole (Persantine) Summary

Description: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)

Also Known As: Persantine; Miosen; Antistenocardin; Apo-Dipyridamole; Apotex Brand of Dipyridamole Show All >>

Networked: 2873 relevant articles (200 outcomes, 546 trials/studies) for this Drug

Key Diseases for which Dipyridamole is Relevant

  1. Stroke (Strokes) : 54 outcomes 109 studies in 305 results
  2. Coronary Artery Disease (Coronary Atherosclerosis) : 13 outcomes 85 studies in 532 results
  3. Myocardial Infarction : 13 outcomes 56 studies in 261 results
  4. Myocardial Ischemia (Ischemic Heart Diseases) : 13 outcomes 20 studies in 220 results
  5. Ischemia : 8 outcomes 29 studies in 207 results
Show All >>

Drugs Related to Dipyridamole

  1. Aspirin (Acetylsalicylic Acid)
  2. clopidogrel (Plavix)
  3. Platelet Aggregation Inhibitors (Antiplatelet Drugs)
  4. Thallium
  5. Adenosine
  6. Ticlopidine (Ticlid)
  7. Prednisolone (Predate)
  8. Dobutamine
  9. Warfarin (Coumadin)
  10. Dipyridamole (Persantine)
Show All >>

Therapies Related to Dipyridamole

  1. Transplants (Transplant)
  2. Coronary Artery Bypass (Coronary Artery Bypass Surgery)
  3. Renal Dialysis (Hemodialysis)
  4. Prostheses and Implants (Prosthesis)
  5. Angioplasty (Angioplasty, Transluminal)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.